Thursday, September 24, 2020 10:43:26 AM
From broken contracts with weak companies, Medipharm learned they have to evolve their business model; now they are putting products out and going international with focus on medicinal.
ACB with miserable $1. I think 4? BILLION quarterly loss, well the newEST CEO says they have to go basically in same direction as Medipharm, create new products, find international partners/deals, etc, only they are losing so much money and falling so far behind, so quickly.
Makes MEDIF$ look prescient today and obviously we all hope they can report significant revenues from these recent deals in future quarters.
Also hopefully there is a point at which it is more risky to sell at these lows than hold on for good news from the new efforts.
glta
MEDIF$
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM